Artificial Intelligence in Medicine
Volume 44, Issue 3 , Pages 221-231 , November 2008

Using support vector regression to model the correlation between the clinical metastases time and gene expression profile for breast cancer

  • Shih-Hau Chiu

      Affiliations

    • Institute of Molecular Medicine & Department of Life Science, National Tsing Hua University, HsinChu, Taiwan
    • Bioresource Collection and Research Center, Food Industry Research and Development Institute, HsinChu, Taiwan
    • ,
  • Chien-Chi Chen

      Affiliations

    • Bioresource Collection and Research Center, Food Industry Research and Development Institute, HsinChu, Taiwan
    • ,
  • Thy-Hou Lin

      Affiliations

    • Institute of Molecular Medicine & Department of Life Science, National Tsing Hua University, HsinChu, Taiwan
    • Corresponding Author InformationCorresponding author at: Institute of Molecular Medicine & Department of Life Science, National Tsing Hua University, HsinChu, Taiwan. Tel.: +886 3 574 2759; fax: +886 3 571 5934.

Received 11 December 2007 ,Revised 13 May 2008 ,Accepted 25 June 2008.

References 

  1. Fan C, Oh DS, Wessels L, Weigelt B, Nuyten DS, Nobel AB, et al. Concordance among gene-expression-based predictors for breast cancer. N Engl J Med. 2006;355(6):560–569
  2. Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005;365(9460):671–679
  3. van de Vijver MJ, He YD, van’t Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347(25):1999–2009
  4. Glinsky GV, Higashiyama T, Glinskii AB. Classification of human breast cancer using gene expression profiling as a component of the survival predictor algorithm. Clin Cancer Res. 2004;10(7):2272–2283
  5. Eden P, Ritz C, Rose C, Ferno M, Peterson C. Good Old clinical markers have similar power in breast cancer prognosis as microarray gene expression profilers. Eur J Cancer. 2004;40(12):1837–1841
  6. Dai H, van’t Veer L, Lamb J, He YD, Mao M, Fine BM, et al. A cell proliferation signature is a marker of extremely poor outcome in a subpopulation of breast cancer patients. Cancer Res. 2005;65(10):4059–4066
  7. Michiels S, Koscielny S, Hill C. Prediction of cancer outcome with microarrays: a multiple random validation strategy. Lancet. 2005;365(9458):488–492
  8. Husmeier D. Sensitivity and specificity of inferring genetic regulatory interactions from microarray experiments with dynamic Bayesian networks. Bioinformatics. 2003;19(17):2271–2282
  9. Perrin BE, Ralaivola L, Mazurie A, Bottani S, Mallet J, D’Alche-Buc F. Gene networks inference using dynamic Bayesian networks. Bioinformatics. 2003;19(Suppl 2):II138–II148
  10. Yeung KY, Bumgarner RE. Multiclass classification of microarray data with repeated measurements: application to cancer. Genome Biol. 2003;4(12):R83
  11. Berrar DP, Downes CS, Dubitzky W. Multiclass cancer classification using gene expression profiling and probabilistic neural networks. Pac Symp Biocomput. 2003;5–16
  12. Bair E, Tibshirani R. Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol. 2004;2(4):E108
  13. Zou M, Conzen SD. A new dynamic Bayesian network (DBN) approach for identifying gene regulatory networks from time course microarray data. Bioinformatics. 2005;21(1):71–79
  14. Liu JJ, Cutler G, Li W, Pan Z, Peng S, Hoey T, et al. Multiclass cancer classification and biomarker discovery using GA-based algorithms. Bioinformatics. 2005;21(11):2691–2697
  15. Sha N, Tadesse MG, Vannucci M. Bayesian variable selection for the analysis of microarray data with censored outcomes. Bioinformatics. 2006;22(18):2262–2268
  16. van’t Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415(6871):530–536
  17. Alexe G, Alexe S, Axelrod DE, Bonates TO, Lozina II, Reiss M, et al. Breast cancer prognosis by combinatorial analysis of gene expression data. Breast Cancer Res. 2006;8(4):R41
  18. Gevaert O, De Smet F, Timmerman D, Moreau Y, De Moor B. Predicting the prognosis of breast cancer by integrating clinical and microarray data with Bayesian networks. Bioinformatics. 2006;22(14):e184–e190
  19. Ein-Dor L, Kela I, Getz G, Givol D, Domany E. Outcome signature genes in breast cancer: is there a unique set?. Bioinformatics. 2005;21(2):171–178
  20. Brenton JD, Carey LA, Ahmed AA, Caldas C. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol. 2005;23(29):7350–7360
  21. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, et al. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;351(27):2817–2826
  22. Witten IH, Frank E. Data mining: practical machine learning tools and techniques. 2nd ed.. San Francisco: Morgan Kaufmann; 2005;
  23. Kohavi R, John GH. Wrappers for feature subset selection. Artif Intell. 1997;97(1–2):273–324
  24. Chang C-C, Lin C-J. LIBSVM: a library for support vector machines, 2001. Software available at http://www.csie.ntu.edu.tw/∼cjlin/libsvm.
  25. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003;4(5):P3
  26. Allinen M, Beroukhim R, Cai L, Brennan C, Lahti-Domenici J, Huang H, et al. Molecular characterization of the tumor microenvironment in breast cancer. Cancer Cell. 2004;6(1):17–32
  27. O'Shaughnessy JA. Molecular signatures predict outcomes of breast cancer. N Engl J Med. 2006;355(6):615–617

PII: S0933-3657(08)00085-7

doi: 10.1016/j.artmed.2008.06.005

Artificial Intelligence in Medicine
Volume 44, Issue 3 , Pages 221-231 , November 2008

Article Tools

* Image Usage & Resolution